Hao Wang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 22

Top Topics

Prostate Cancer

Radical Prostatectomy

Top Venues

Cancer research communications

Nature communications

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Mark C Markowski, Mary-Ellen Taplin, Rahul R Aggarwal, Laura A Sena, Hao Wang, Hanfei Qi, Aliya Lalji, Victoria Sinibaldi, Michael A Carducci, Channing J Paller, Catherine H Marshall, Mario A Eisenberger, David E Sanin, Srinivasan Yegnasubramanian, Carolina Gomes-Alexandre, Busra Ozbek, Tracy Jones, Angelo M DeMarzo, Samuel R Denmeade, Emmanuel S Antonarakis
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial. Nature communications 15 (1) (2024)
Mark C Markowski, Mary-Ellen Taplin, Rahul R Aggarwal, Laura A Sena, Hao Wang, Hanfei Qi, Aliya Lalji, Victoria Sinibaldi, Michael A Carducci, Channing J Paller, Catherine H Marshall, Mario A Eisenberger, David E Sanin, Srinivasan Yegnasubramanian, Carolina Gomes-Alexandre, Busra Ozbek, Tracy Jones, Angelo M DeMarzo, Samuel R Denmeade, Emmanuel S Antonarakis
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial. Nature communications 15 (1) (2024)
Chiaki T Ishida, Stephanie L Myers, Casie S Kubota, Wei Shao, Meredith R McGuire, Chune Liu, Theodore E Ewachiw, Debaditya Mukhopadhyay, Suqi Ke, Hao Wang, Zeshaan A Rasheed, Robert A Anders, Peter J Espenshade
SREBP-dependent regulation of lipid homeostasis is required for progression and growth of pancreatic ductal adenocarcinoma. Cancer research communications (2024)
Mark C Markowski, Mary-Ellen Taplin, Rahul R Aggarwal, Laura A Sena, Hao Wang, Hanfei Qi, Aliya Lalji, Victoria Sinibaldi, Michael A Carducci, Channing J Paller, Catherine H Marshall, Mario A Eisenberger, David E Sanin, Srinivasan Yegnasubramanian, Carolina Gomes-Alexandre, Busra Ozbek, Tracy Jones, Angelo M DeMarzo, Samuel R Denmeade, Emmanuel S Antonarakis
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial. Nature communications 15 (1) (2024)
Mark C Markowski, Mary-Ellen Taplin, Rahul R Aggarwal, Laura A Sena, Hao Wang, Hanfei Qi, Aliya Lalji, Victoria Sinibaldi, Michael A Carducci, Channing J Paller, Catherine H Marshall, Mario A Eisenberger, David E Sanin, Srinivasan Yegnasubramanian, Carolina Gomes-Alexandre, Busra Ozbek, Tracy Jones, Angelo M DeMarzo, Samuel R Denmeade, Emmanuel S Antonarakis
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial. Nature communications 15 (1) (2024)
Sarah E Laun, Lisa Kann, Jerome Braun, Stacey Gilbert, Daniel Lunz, Francia Pierre, Andrew Kalra, Ke Ma, Hua-Ling Tsai, Hao Wang, Simran Jit, Yulan Cheng, Yousra Ahmed, Kenneth K Wang, Cadman L Leggett, Ashley Cellini, Olga B Ioffe, Blair A Jobe, Ashten N Omstead, Blair Jobe, Louis Korman, Drew Cornish, Pauline Zellenrath, Manon C W Spaander, Ernst J Kuipers, Lorrie Perpetua, Bruce D Greenwald, Tara Maddala, Stephen J Meltzer
Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients with Barrett's Esophagus. The American journal of gastroenterology (2024)
Eugene Shenderov, Angelo M DeMarzo, Tamara L Lotan, Hao Wang, Sin Chan, Su Jin Lim, Hongkai Ji, Mohamad E Allaf, Carolyn Chapman, Paul A Moore, Francine Chen, Kristina Sorg, Andrew M White, Sarah E Church, Briana Hudson, Paul A Fields, Shaohui Hu, Samuel R Denmeade, Kenneth J Pienta, Christian P Pavlovich, Ashley E Ross, Charles G Drake, Drew M Pardoll, Emmanuel S Antonarakis
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial. Nature medicine (2023)
Channing J Paller, Lin Wang, Wei Fu, Rajendra Kumar, Jennifer N Durham, Nilofer S Azad, Daniel A Laheru, Ilene Browner, Sushant K Kachhap, Kavya Boyapati, Thomas A Odeny, Deborah K Armstrong, Christian F Meyer, Stephanie Gaillard, Julie R Brahmer, Ivelisse Page, Hao Wang, Luis A Diaz
Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer. Cancer research communications 3 (2) (2023)
Laura A Sena, Hao Wang, Samuel R Denmeade
First, do no harm: The unclear benefit of lifelong castration for patients with metastatic prostate cancer. The Prostate (2023)
Thatcher Heumann, Carol Judkins, Keyu Li, Su Jin Lim, Jessica Hoare, Rose Parkinson, Haihui Cao, Tengyi Zhang, Jessica Gai, Betul Celiker, Qingfeng Zhu, Thomas McPhaul, Jennifer Durham, Katrina Purtell, Rachel Klein, Daniel Laheru, Ana De Jesus-Acosta, Dung T Le, Amol Narang, Robert A Anders, Richard Burkhart, William Burns, Kevin C Soares, Christopher Wolfgang, Elizabeth Thompson, Elizabeth D Thompson, Hao Wang, Jin He, Lei Zheng
A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma. Nature communications 14 (1) (2023)
Ioanna Liatsou, Yingli Fu, Zhi Li, Mahmud Hasan, Xin Guo, Jing Yu, Joseph Piccolo, Allison G Cartee, Hao Wang, Yong Du, Jeffrey N Bryan, Kathleen Gabrielson, Dara L Kraitchman, George Sgouros
Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma-a proof of concept study. European journal of nuclear medicine and molecular imaging (2023)
Ioanna Liatsou, Yingli Fu, Zhi Li, Mahmud Hasan, Xin Guo, Jing Yu, Joseph Piccolo, Allison G Cartee, Hao Wang, Yong Du, Jeffrey N Bryan, Kathleen Gabrielson, Dara L Kraitchman, George Sgouros
Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma-a proof of concept study. European journal of nuclear medicine and molecular imaging 51 (5) (2023)
Ioanna Liatsou, Yingli Fu, Zhi Li, Mahmud Hasan, Xin Guo, Jing Yu, Joseph Piccolo, Allison G Cartee, Hao Wang, Yong Du, Jeffrey N Bryan, Kathleen Gabrielson, Dara L Kraitchman, George Sgouros
Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma-a proof of concept study. European journal of nuclear medicine and molecular imaging 51 (5) (2023)
Helen Catherine Wilbur, Jennifer N Durham, Su Jin Lim, Katrina Purtell, Katherine M Bever, Daniel A Laheru, Ana M C De Jesus-Acosta, Nilofer S Azad, Bradley Wilt, Luis A Diaz, Dung T Le, Hao Wang
Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer. Cancer research communications 3 (8) (2023)
Channing J Paller, Lin Wang, Wei Fu, Rajendra Kumar, Jennifer N Durham, Nilofer S Azad, Daniel A Laheru, Ilene Browner, Sushant K Kachhap, Kavya Boyapati, Thomas A Odeny, Deborah K Armstrong, Christian F Meyer, Stephanie Gaillard, Julie R Brahmer, Ivelisse Page, Hao Wang, Luis A Diaz
Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer. Cancer research communications 3 (2) (2023)
Eric S Christenson, Su Jin Lim, Jennifer N Durham, Ana M C De Jesus-Acosta, Katherine M Bever, Daniel A Laheru, Amy Ryan, Parul Agarwal, Robert B Scharpf, Dung T Le, Hao Wang
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma. Cancer research communications 2 (11) (2022)
Eric S Christenson, Su Jin Lim, Jennifer N Durham, Ana M C De Jesus-Acosta, Katherine M Bever, Daniel A Laheru, Amy Ryan, Parul Agarwal, Robert B Scharpf, Dung T Le, Hao Wang
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma. Cancer research communications 2 (11) (2022)
Samuel R Denmeade, Su J Lim, Pedro Isaaccson Velho, Hao Wang
PSA provocation by bipolar androgen therapy may predict duration of response to first-line androgen deprivation: Updated results from the BATMAN study. The Prostate 82 (16) (2022)
Philip Sutera, Kim Van Der Eecken, Amar U Kishan, Anis Hamid, Emily Grist, Gerhardt Attard, Tamara Lotan, Adrianna A Mendes, Channing J Paller, Michael A Carducci, Ashley Evan Ross, Hao Wang, Kenneth J Pienta, Felix Y Feng, Emmanuel S Antonarakis, Piet Ost, Daniel Y Song, Stephen Greco, Curtiland Deville, Theodore DeWeese, Phuoc T Tran, Matthew P Deek
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics. Prostate cancer and prostatic diseases 25 (4) (2022)
Emily Nizialek, Su Jin Lim, Hao Wang, Pedro Isaacsson Velho, Srinivasan Yegnasubramanian, Emmanuel S Antonarakis
Genomic profiles and clinical outcomes in primary versus secondary metastatic hormone-sensitive prostate cancer. The Prostate 81 (9) (2021)
Fadi Taza, Albert E Holler, Wei Fu, Hao Wang, Nabil Adra, Costantine Albany, Ryan Ashkar, Heather H Cheng, Alexandra O Sokolova, Archana M Agarwal, Adam Kessel, Alan H Bryce, Nellie Nafissi, Pedro C Barata, A Oliver Sartor, Diogo Assed Bastos, Oren Smaletz, Jacob E Berchuck, Mary-Ellen Taplin, Rahul R Aggarwal, Cora N Sternberg, Panagiotis J Vlachostergios, Ajjai S Alva, Christopher T Su, Catherine Handy Marshall, Emmanuel S Antonarakis
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 5 (2021)
Eugene Shenderov, Karim Boudadi, Wei Fu, Hao Wang, Rana Sullivan, Alice Jordan, Donna Dowling, Rana Harb, Joseph Schonhoft, Adam Jendrisak, Michael A Carducci, Mario A Eisenberger, James R Eshleman, Jun Luo, Charles G Drake, Drew M Pardoll, Emmanuel S Antonarakis
Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial. The Prostate 81 (6) (2021)